{"id":5289,"date":"2020-12-29T11:04:00","date_gmt":"2020-12-29T11:04:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/"},"modified":"2024-09-23T11:22:29","modified_gmt":"2024-09-23T11:22:29","slug":"nasale-glucagon-per-1-januari-vergoed","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/","title":{"rendered":"Nasale glucagon per 1 januari vergoed"},"content":{"rendered":"<p>Goed nieuws voor mensen met type 1 diabetes die last hebben van ernstige hypo\u2019s. Per 1 januari 2021 is er een alternatief voor de bekende glucagonkit. In plaats van een injectie met glucagon, is de goedgekeurde Baqsimi een neuspoeder dat opgesnoven kan worden. Deze vorm van glucagon zal voor velen een prettigere oplossing voor ernstige hypoglykemie\u00ebn zijn.<br \/><\/p>\n<p>Want zo schreven wij begin van dit jaar: \u201cErnstige hypoglykemie\u00ebn kunnen een dramatische impact hebben op het leven van mensen met type 1 diabetes en betrokkenen. De huidige behandeling van een ernstige hypo met behulp van een glucagonkit schiet tekort.\u201d Breakthrough T1D is dan ook zeer verheugd dat <a href=\"https:\/\/www.zorginstituutnederland.nl\/publicaties\/adviezen\/2020\/11\/05\/gvs-advies-glucagon-neuspoeder-baqsimi\">nasale glucagon is goedgekeurd \u00e9n per 1 januari vergoed wordt vanuit de basisverzekering<\/a>.<\/p>\n<p>Dat ernstige hypoglykemie\u00ebn veel impact kunnen hebben, bleek wel uit de reacties die we destijds ontvingen op de aankondiging van nasale glucagon. Zo bleken familieleden vaak angstig om de glucagonpen te gebruiken en gaf 79% van de mensen aan dat ze glucagon sneller zouden gebruiken als ze de keuze hadden voor een neusspray. Daarom is het goed dat deze variant van glucagon per 1 januari ook daadwerkelijk breder gebruikt kan worden.<\/p>\n<p><a href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/jdrf-nederland-pleit-voor-toelating-en-vergoeding-nasale-glucagon\/\">Lees het statement van Breakthrough T1D Nederland van januari 2020 hier<\/a>.<\/p>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Goed nieuws voor mensen met type 1 diabetes die last hebben van ernstige hypo\u2019s. Per 1 januari 2021 is er een alternatief voor de bekende glucagonkit. In plaats van een injectie met glucagon, is de goedgekeurde Baqsimi een neuspoeder dat opgesnoven kan worden. Deze vorm van glucagon zal voor velen een prettigere oplossing voor ernstige [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5290,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,187],"tags":[],"class_list":["post-5289","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-archief","category-behandelen"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nasale glucagon per 1 januari vergoed - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nasale glucagon per 1 januari vergoed - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Goed nieuws voor mensen met type 1 diabetes die last hebben van ernstige hypo\u2019s. Per 1 januari 2021 is er een alternatief voor de bekende glucagonkit. In plaats van een injectie met glucagon, is de goedgekeurde Baqsimi een neuspoeder dat opgesnoven kan worden. Deze vorm van glucagon zal voor velen een prettigere oplossing voor ernstige [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-29T11:04:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"240\" \/>\n\t<meta property=\"og:image:height\" content=\"187\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Nasale glucagon per 1 januari vergoed\",\"datePublished\":\"2020-12-29T11:04:00+00:00\",\"dateModified\":\"2024-09-23T11:22:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/\"},\"wordCount\":203,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg\",\"articleSection\":[\"Archief\",\"Behandelen\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/\",\"name\":\"Nasale glucagon per 1 januari vergoed - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg\",\"datePublished\":\"2020-12-29T11:04:00+00:00\",\"dateModified\":\"2024-09-23T11:22:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#primaryimage\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg\",\"width\":240,\"height\":187},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nasale glucagon per 1 januari vergoed\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nasale glucagon per 1 januari vergoed - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/","og_locale":"nl_NL","og_type":"article","og_title":"Nasale glucagon per 1 januari vergoed - Breakthrough T1D","og_description":"Goed nieuws voor mensen met type 1 diabetes die last hebben van ernstige hypo\u2019s. Per 1 januari 2021 is er een alternatief voor de bekende glucagonkit. In plaats van een injectie met glucagon, is de goedgekeurde Baqsimi een neuspoeder dat opgesnoven kan worden. Deze vorm van glucagon zal voor velen een prettigere oplossing voor ernstige [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/","og_site_name":"Breakthrough T1D","article_published_time":"2020-12-29T11:04:00+00:00","article_modified_time":"2024-09-23T11:22:29+00:00","og_image":[{"width":240,"height":187,"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg","type":"image\/jpeg"}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Nasale glucagon per 1 januari vergoed","datePublished":"2020-12-29T11:04:00+00:00","dateModified":"2024-09-23T11:22:29+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/"},"wordCount":203,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg","articleSection":["Archief","Behandelen"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/","name":"Nasale glucagon per 1 januari vergoed - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg","datePublished":"2020-12-29T11:04:00+00:00","dateModified":"2024-09-23T11:22:29+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#primaryimage","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2020\/12\/46057881342_118aedb30e_m_neusspray-3.jpg","width":240,"height":187},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nasale-glucagon-per-1-januari-vergoed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Nasale glucagon per 1 januari vergoed"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5289"}],"version-history":[{"count":2,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5289\/revisions"}],"predecessor-version":[{"id":8864,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5289\/revisions\/8864"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media\/5290"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}